We are live on
!
Find out more
SAM
Sagewood Asset Management Portfolio holdings
AUM
$442M
This Fund
S&P 500
This Quarter
Est. Return
+3.15%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$282M
AUM Growth
–
Cap. Flow
+$279M
Cap. Flow
% of AUM
98.9%
Top 10 Holdings %
Top 10 Hldgs %
42.07%
Holding
264
New
264
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Berkshire Hathaway Class B
BRK.B
|
+$29.6M |
| 2 |
Berkshire Hathaway Class A
BRK.A
|
+$14.2M |
| 3 |
Microsoft
MSFT
|
+$12.9M |
| 4 |
Apple
AAPL
|
+$11.5M |
| 5 |
NVIDIA
NVDA
|
+$11.1M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 31.59% |
| 2 | Technology | 23.12% |
| 3 | Consumer Staples | 8.53% |
| 4 | Communication Services | 7.16% |
| 5 | Healthcare | 7.06% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
251
Kosmos Energy
KOS
$1.57B
| $41.6K | 0.01% |
+45,890
| New | +$60.5K |
|
252
Microvision
MVIS
$54.4M
| $27.8K | 0.01% |
+2,240
| New | +$35.7K |
|
253
Geron
GERN
$977M
| $25.1K | 0.01% |
+19,017
| New | +$23.9K |
|
254
Allogene Therapeutics
ALLO
$726M
| $22.8K | 0.01% |
+16,625
| New | +$21.9K |
|
|
TEAD
255
Teads Holding Co
TEAD
$53M
| $21.9K | 0.01% |
+31,131
| New | +$33K |
|
256
MaxCyte
MXCT
$138M
| $21.1K | 0.01% |
+13,598
| New | +$21.7K |
|
257
Coherus Oncology
CHRS
$209M
| $20.9K | 0.01% |
+14,732
| New | +$21.5K |
|
258
Accuray
ARAY
$32.5M
| $18.8K | 0.01% |
+22,793
| New | +$28.5K |
|
259
PLAYSTUDIOS Inc
MYPS
$59.7M
| $16.7K | 0.01% |
+25,629
| New | +$20K |
|
260
Agilon Health
AGL
$1.64B
| $15.8K | 0.01% |
+918
| New | +$17.8K |
|
261
Fate Therapeutics
FATE
$302M
| $14.7K | 0.01% |
+15,003
| New | +$18K |
|
262
Standard BioTools
LAB
$252M
| $13.1K | ﹤0.01% |
+10,271
| New | +$13.8K |
|
263
Advantage Solutions
ADV
$422M
| $12.7K | ﹤0.01% |
+576
| New | +$16.6K |
|
264
BRC Inc
BRCC
$127M
| $12K | ﹤0.01% |
+1,079
| New | +$14K |
|
Similar funds
DA
CPWA
HH
FPTW
BIP
TPWA
ASP
EC
Sagewood Asset Management's Q4 2025 Portfolio in Review
Q4 2025 is the first quarter with a 13F filing on record for Sagewood Asset Management, which disclosed 264 positions worth $282M. Its ten largest holdings account for 42% of the portfolio.
Its largest position is Berkshire Hathaway Class B: 59,502 shares worth $29.9M.
By sector, the portfolio is most concentrated in Financials at 32% of assets, followed by Technology and Consumer Staples.
- Sagewood Asset Management's largest Q4 2025 buy was Berkshire Hathaway Class B: 59,502 shares worth $29.9M.
- Sagewood Asset Management's ten largest holdings make up 42% of its $282M portfolio in Q4 2025.
- Sagewood Asset Management disclosed 264 positions in Q4 2025, its first 13F filing on record.
Based on Sagewood Asset Management's 13F filing for Q4 2025, filed 17 Feb 2026.